Real-World Evaluation of the Efficacy of Third-Line Treatment Regimens for Advanced Gastric Cancer: A Single-Center Retrospective Study
Patients receiving third-line chemotherapy combined with immune or targeted therapy achieve the longest MST; however, this regimen is also associated with a higher incidence of adverse events and overall treatment costs.
Authors
- Yu Sun (ORCID: https://orcid.org/0000-0003-2306-7200)
- Chouwen Zhu
- Xiaoling Zhou
- Tianshu Liu
Institutions
- Fudan University (CN)
- ShanghaiTech University (CN)
- Zhongshan Hospital (CN)
- Shanghai Clinical Research Center (CN)
Publication Details
- Journal
- British Journal of Hospital Medicine
- Published
- 2026-02-11
- DOI
- https://doi.org/10.31083/bjhm50918
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fudan University